Comparison of a new trifocal IOL with PanOptix Pro IOL in cataract surgery
Official title: Clinical Evaluation of a Novel Trifocal IOL
Run by Alcon Research · NCT07587138 · Data updated 2026-11-12
This study tests whether the investigational trifocal IOL LPYWT0 works as well as the PanOptix Pro trifocal IOL in people with cataracts undergoing cataract surgery in both eyes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Alcon Research Industry-sponsored |
| Locations | 5 sites (Sydney, New South Wales and 4 other locations) |
| Status | Recruiting |
| Started | October 9, 2026 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07587138 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing bilateral cataract surgery who meet specific refractive and ocular criteria, including appropriate IOL power between +15.0 and +25.0 D and low astigmatism (<1.00 D) in each eye, and the potential to achieve 0.2 logMAR or better with correction.
✕Probably not a fit
Patients with significant corneal disease, systemic or ocular conditions that could compromise results, or unsuitable IOL power/eye health may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with bilateral cataracts will have sequential cataract surgery, receiving the investigational LPYWT0 trifocal IOL in one eye and the commercially available PXYWT0 PanOptix Pro trifocal IOL in the other eye, about 7–14 days apart. The trial plans about 9 visits over roughly 7 months to compare visual outcomes between the two eyes. The study is conducted in India and the Philippines and aims to characterize the visual performance of the LPYWT0 IOL relative to a marketed trifocal lens.
Why it matters
Potential benefit: If successful, patients could gain access to a potentially new trifocal IOL option that may provide good vision at multiple distances.
How similar studies have gone: Previous studies with similar comparative approaches have shown mixed results; this study addresses a novel investigational IOL by direct comparison to an established trifocal lens.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: * The calculated power needed for the artificial lens (IOL) must be between +15.0 and +25.0 D in each eye, designed to bring subject vision as close to "0.0" (neutral) as possible, meaning they will not be strongly nearsighted or farsighted after surgery. * Subjects must have low levels of astigmatism (misshapen cornea) in the eyes (less than 1.00 D). * In the doctor's opinion, the subjects have the potential to achieve good vision (0.2 logMAR, which is roughly 20/32 Snellen or better) in each eye after the surgery, when wearing the best possible spectacles or contact lenses. * Other protocol-specified inclusion criteria may apply. Key Exclusion Criteria: * Clinically significant corneal diseases which may, according to the investigator's medical opinion, adversely affect visual outcomes. * Any ocular or systemic health condition or medical issue that, in the investigator's medical opinion, could make the study results unreliable, prevent the person from finishing the study, or increase their safety risk. * People who want to have one eye set for distance vision and the other for near vision. * The doctor expects significant blurry vision (astigmatism) after the procedure. * Other protocol-specified exclusion criteria may apply.
Where it's running
-
Asian Eye Institute
Makati City, Philippines Recruiting -
Personaleyes
Sydney, New South Wales, Australia Not yet recruiting -
Dr. Agarwal's Eye Hospital Limited
Chennai, Tamil Nadu, India Not yet recruiting -
Narayana Nethralaya
Bangalore, India Not yet recruiting -
Peregrine Eye Laser and Institute
Makati City, Manila, Philippines Not yet recruiting
Study contacts
- Study coordinator: Alcon Call Center
- Email: alcon.medinf@alcon.com
- Phone: 1-888-451-3937
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.